Yahoo
NYSE - Delayed Quote USD

Emergent BioSolutions Inc. (EBS)

6.81 -0.41 (-5.68%)
At close: October 30 at 4:00:02 PM EDT
6.81 0.00 (0.00%)
After hours: October 30 at 4:01:27 PM EDT
Trade EBS on Coinbase
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
742,300
705,200
1,013,600
1,023,000
1,076,100
Cost of Revenue
339,900
326,200
681,300
705,400
693,100
Gross Profit
402,400
379,000
332,300
317,600
383,000
Operating Expense
264,900
266,700
413,800
519,100
546,300
Operating Income
137,500
112,300
-81,500
-201,500
-163,300
Net Non Operating Interest Income Expense
-50,900
-59,300
-71,000
-87,900
-37,300
Other Income Expense
-232,600
29,800
9,600
-441,800
-18,400
Pretax Income
-146,000
82,800
-142,900
-731,200
-219,000
Tax Provision
30,800
30,200
47,700
29,300
-7,400
Net Income Common Stockholders
-176,800
52,600
-190,600
-760,500
-211,600
Diluted NI Available to Com Stockholders
-176,800
52,600
-190,600
-760,500
-211,600
Basic EPS
-3.40
0.98
-3.60
-14.85
-4.22
Diluted EPS
-3.41
0.93
-3.60
-14.85
-4.22
Basic Average Shares
52,200
53,500
53,000
51,200
50,100
Diluted Average Shares
54,200
56,700
53,000
51,200
50,100
Total Operating Income as Reported
-66,000
100,100
-108,700
-726,400
-170,000
Total Expenses
604,800
592,900
1,095,100
1,224,500
1,239,400
Net Income from Continuing & Discontinued Operation
-176,800
52,600
-190,600
-760,500
-211,600
Normalized Income
-35,980
68,094
-188,889.49
-427,801.14
-205,101
Interest Expense
50,900
59,300
71,000
87,900
37,300
Net Interest Income
-50,900
-59,300
-71,000
-87,900
-37,300
EBIT
-95,100
142,100
-71,900
-643,300
-181,700
EBITDA
-700
237,900
36,900
-518,200
-38,400
Reconciled Cost of Revenue
311,800
295,500
637,600
645,900
609,700
Reconciled Depreciation
94,400
95,800
108,800
125,100
143,300
Net Income from Continuing Operation Net Minority Interest
-176,800
52,600
-190,600
-760,500
-211,600
Total Unusual Items Excluding Goodwill
-234,700
-24,400
-2,300
-448,200
-6,700
Total Unusual Items
-234,700
-24,400
-2,300
-448,200
-6,700
Normalized EBITDA
234,000
262,300
39,200
-70,000
-31,700
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-93,880
-8,906
-589.49
-115,501.14
-201
12/31/2022 - 11/15/2006

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: